Preclinical development of a new kinase inhibitor for copd

Ended Project Grant Awarded Last action

Award ID
W81XWH2010603
Recipient
Awarding agency
Obligated
$3,928,669

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Originally
Place of performance
University City, MO 63130, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment Preclinical development of a new kinase inhibitor for copd extend the period of performance 1. Per section 711 of the national defense authorization act… $0
Original award $3,928,669

Subawards

Subrecipient Amount Awarded
Nupeak Therapeutics Inc. STATEMENT OF WORK – 07/11/2019 PROPOSED START DATE September 1, 2019 Site 1: Washington University Site 2: NuPeak Therapeutics Inc. 660 South Euclid Ave.… -$140,000
Nupeak Therapeutics Inc. STATEMENT OF WORK – 07/11/2019 PROPOSED START DATE September 1, 2019 Site 1: Washington University Site 2: NuPeak Therapeutics Inc. 660 South Euclid Ave.… $545,743
Nupeak Therapeutics Inc. STATEMENT OF WORK � 07/11/2019 PROPOSED START DATE September 1, 2019 Site 1: Washington University Site 2: NuPeak Therapeutics Inc. 660 South Euclid Ave.… $493,357

Quick answers

Who received award W81XWH2010603?

W81XWH2010603 was awarded to The Washington University by Defense Health Agency (Department of Defense) on July 15, 2020.

How much is award W81XWH2010603 worth?

$3,928,669 has been obligated on W81XWH2010603.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login